Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD49 pseudogene 3 is classified as a pseudogene, meaning it is a nonfunctional genomic sequence with homology to the protein-coding ankyrin repeat domain 49 (ANKRD49) gene. Pseudogenes do not encode functional proteins and are generally not considered therapeutic targets. There is no evidence that ANKRD49P3 is involved in biological functions, human disease, or responses to drugs. Pseudogenes may occasionally be transcribed, but evidence for ANKRD49P3-specific transcription or function is lacking[4][5].\nThe ANKRD49 gene (not ANKRD49P3) encodes ankyrin repeat domain 49 and has described functions in transcriptional regulation and potential involvement in cancer[1][2][3]; however, the pseudogene ANKRD49P3 does not share these functional properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD49 pseudogene 3 (ANKRD49P3).